ARS Pharmaceuticals (SPRY) Financials: Revenue & Earnings
SPRY$3.60-0.14 -3.62%
$357.51M
Market Cap
—
P/E
—
Forward P/E
—
Score
ARS Pharmaceuticals (SPRY) Financials: Revenue & Earnings
SPRY price $3.60 -0.14 -3.62%
- Ticker
- SPRY
- Price
- $3.60
- Change
- -0.14 -3.62%
- Market cap ?
- $357.51M
- Beta ?
- 0.88
- Sector
- Healthcare
- Industry
- Biotechnology
Fair value
SPRY fair value $12.04. Price $3.60. Price is 70% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 15.00M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 9.12% (beta 0.9). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 99.45M. Net debt 55.06M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Model uncertainty high for this stock
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-09 | — | -0.34 | — | 41.99M |
| 2026-08-13 | -0.63 | -0.48 | 33.66M | 31.32M |
| 2026-05-15 | -0.61 | -0.53 | 22.68M | 22.20M |
| 2026-03-09 | -0.42 | -0.42 | 28.10M | 25.62M |
| 2025-11-10 | -0.52 | -0.45 | 32.50M | 25.58M |
| 2025-08-13 | -0.46 | -0.41 | 15.72M | 27.67M |
| 2025-05-14 | -0.35 | -0.35 | 7.97M | 14.71M |
| 2025-03-20 | 0.52 | -0.04 | 86.58M | 12.84M |
| 2024-11-13 | -0.20 | -0.18 | 2.07M | 17.08M |
| 2024-08-06 | -0.13 | -0.12 | 500.00K | 1.00M |
| 2024-05-09 | -0.11 | -0.11 | — | — |
| 2024-03-21 | -0.07 | -0.14 | 30.00K | — |
| 2023-11-09 | -0.16 | -0.18 | — | — |
| 2023-08-10 | -0.18 | -0.17 | 10.00K | — |
| 2023-05-15 | -0.16 | -0.17 | 20.00K | — |
| 2023-03-23 | 0.77 | -0.13 | 1.32M | 90.00K |
| 2022-11-02 | -0.50 | -0.35 | 189.00K | — |
| 2022-08-11 | -0.55 | -0.48 | 464.00K | — |
| 2022-05-12 | -0.70 | -0.54 | 663.00K | — |
| 2022-03-31 | -0.67 | -0.70 | 754.00K | — |
| 2021-11-10 | -0.65 | -0.67 | 528.00K | — |
| 2021-08-12 | -0.70 | -0.53 | 2.11M | — |
| 2021-05-13 | -0.54 | -0.35 | 2.11M | — |
| 2021-03-29 | -1.37 | -0.49 | — | — |
| 2020-11-10 | -0.19 | — | — | — |
| 2020-03-31 | -0.16 | — | — | — |
| 2019-12-31 | -0.21 | — | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-01 | Casale Donn | Buy | 1.04M | $4.12 | 4.27M |
| 2026-09-01 | Smith Margaret Ekins | Buy | 1.00M | $5.77 | 5.78M |
| 2026-08-17 | Smith Margaret Ekins | Other | 0 | — | — |
| 2026-07-01 | Casale Donn | Buy | 898.46K | $7.96 | 7.15M |
| 2026-06-24 | RA CAPITAL MANAGEMENT, L.P. | Buy | 30.00K | $10.54 | 316.20K |
| 2026-06-24 | Dadoo Rajeev | Buy | 30.00K | $10.54 | 316.20K |
| 2026-06-24 | Shah Pratik | Buy | 30.00K | $10.54 | 316.20K |
| 2026-06-24 | Kelly Michael | Buy | 30.00K | $10.54 | 316.20K |
| 2026-06-24 | Islam Saqib | Buy | 30.00K | $10.54 | 316.20K |
| 2026-06-24 | Thompson Peter A. | Buy | 30.00K | $10.54 | 316.20K |
| 2026-06-24 | SAUNDERS BRENT L | Buy | 30.00K | $10.54 | 316.20K |
| 2026-06-24 | SCHNEIDER PHILLIP M | Buy | 30.00K | $10.54 | 316.20K |
| 2026-06-24 | Shawver Laura | Buy | 30.00K | $10.54 | 316.20K |
| 2026-06-12 | Karas Eric | Sell | 25.00K | $1.50 | 37.50K |
| 2026-06-12 | Karas Eric | Buy | 25.00K | $1.50 | 37.50K |
| 2026-06-12 | Karas Eric | Sell | 25.00K | $10.00 | 250.00K |
| 2026-06-12 | Fitzpatrick Alexander A | Sell | 3.35K | $10.00 | 33.55K |
| 2026-06-01 | Casale Donn | Other | 0 | — | — |
| 2026-01-02 | Scott Kathleen D. | Buy | 240.00K | $11.49 | 2.76M |
| 2026-01-02 | Karas Eric | Buy | 240.00K | $11.49 | 2.76M |
| 2026-01-02 | Fitzpatrick Alexander A | Buy | 240.00K | $11.49 | 2.76M |
| 2026-01-02 | Dorsey Brian | Buy | 240.00K | $11.49 | 2.76M |
| 2026-01-02 | Chakma Justin | Buy | 240.00K | $11.49 | 2.76M |
| 2026-01-02 | Tanimoto Sarina | Buy | 875.00K | $11.49 | 10.05M |
| 2026-01-02 | Tanimoto Sarina | Buy | 240.00K | $11.49 | 2.76M |
| 2026-01-02 | Lowenthal Richard E | Buy | 875.00K | $11.49 | 10.05M |
| 2026-01-02 | Lowenthal Richard E | Buy | 240.00K | $11.49 | 2.76M |
| 2025-11-13 | Dorsey Brian | Buy | 21.83K | $0.64 | 13.97K |
| 2025-11-13 | Dorsey Brian | Sell | 21.83K | $8.71 | 190.05K |
| 2025-11-13 | Dorsey Brian | Sell | 21.83K | $0.64 | 13.97K |
| 2025-11-12 | Chakma Justin | Buy | 30.00K | $0.84 | 25.20K |
| 2025-11-12 | Chakma Justin | Sell | 30.00K | $8.91 | 267.36K |
| 2025-11-12 | Chakma Justin | Sell | 30.00K | $0.84 | 25.20K |
| 2025-11-12 | Chakma Justin | Sell | 136.38K | $8.86 | 1.21M |
| 2025-11-12 | Shah Pratik | Sell | 250.00K | — | — |
| 2025-11-12 | Shah Pratik | Sell | 100.00K | — | — |
| 2025-08-21 | Lowenthal Richard E | Sell | 50.00K | $14.49 | 724.35K |
| 2025-08-21 | Scott Kathleen D. | Sell | 12.50K | $1.50 | 18.75K |
| 2025-08-21 | Scott Kathleen D. | Buy | 12.50K | $1.50 | 18.75K |
| 2025-08-21 | Scott Kathleen D. | Sell | 12.50K | $15.00 | 187.50K |
| 2025-08-20 | Tanimoto Sarina | Sell | 37.66K | $14.09 | 530.63K |
| 2025-08-19 | Tanimoto Sarina | Sell | 12.34K | $14.03 | 173.13K |
| 2025-07-01 | Karas Eric | Sell | 15.00K | $1.50 | 22.50K |
| 2025-07-01 | Karas Eric | Buy | 15.00K | $1.50 | 22.50K |
| 2025-07-01 | Karas Eric | Sell | 15.00K | $16.99 | 254.86K |
| 2025-06-27 | Flynn James E | Sell | 370.07K | $18.46 | 6.83M |
| 2025-06-25 | RA CAPITAL MANAGEMENT, L.P. | Buy | 30.00K | $17.26 | 517.80K |
| 2025-06-25 | Dadoo Rajeev | Buy | 30.00K | $17.26 | 517.80K |
| 2025-06-25 | Shah Pratik | Buy | 30.00K | $17.26 | 517.80K |
| 2025-06-25 | Kelly Michael | Buy | 30.00K | $17.26 | 517.80K |
| 2025-06-25 | Islam Saqib | Buy | 30.00K | $17.26 | 517.80K |
| 2025-06-25 | Thompson Peter A. | Buy | 30.00K | $17.26 | 517.80K |
| 2025-06-25 | SAUNDERS BRENT L | Buy | 30.00K | $17.26 | 517.80K |
| 2025-06-25 | SCHNEIDER PHILLIP M | Buy | 30.00K | $17.26 | 517.80K |
| 2025-06-25 | Shawver Laura | Buy | 30.00K | $17.26 | 517.80K |
| 2025-06-18 | Karas Eric | Sell | 15.00K | $1.50 | 22.50K |
| 2025-06-18 | Karas Eric | Buy | 15.00K | $1.50 | 22.50K |
| 2025-06-18 | Karas Eric | Sell | 15.00K | $16.00 | 240.00K |
| 2025-05-20 | Fitzpatrick Alexander A | Sell | 100.00K | $5.58 | 558.00K |
| 2025-05-20 | Fitzpatrick Alexander A | Buy | 100.00K | $5.58 | 558.00K |
| 2025-05-20 | Fitzpatrick Alexander A | Sell | 102.97K | $14.10 | 1.45M |
| 2025-05-20 | SAUNDERS BRENT L | Sell | 120.00K | $1.01 | 121.20K |
| 2025-05-20 | SAUNDERS BRENT L | Buy | 120.00K | $1.01 | 121.20K |
| 2025-05-20 | SAUNDERS BRENT L | Sell | 120.00K | $14.25 | 1.71M |
| 2025-05-20 | Scott Kathleen D. | Sell | 50.00K | $1.50 | 75.00K |
| 2025-05-20 | Scott Kathleen D. | Buy | 50.00K | $1.50 | 75.00K |
| 2025-05-20 | Scott Kathleen D. | Sell | 50.00K | $14.10 | 705.16K |
| 2025-04-07 | Shawver Laura | Buy | 27.49K | $4.85 | 133.34K |
| 2025-04-07 | Shawver Laura | Buy | 22.51K | $4.85 | 109.17K |
| 2025-04-07 | Shawver Laura | Sell | 50.00K | $12.30 | 615.07K |
| 2025-04-07 | Shawver Laura | Sell | 22.51K | $4.85 | 109.17K |
| 2025-04-07 | Shawver Laura | Sell | 27.49K | $4.85 | 133.34K |
| 2025-03-20 | Karas Eric | Sell | 10.00K | $1.50 | 15.00K |
| 2025-03-20 | Karas Eric | Buy | 10.00K | $1.50 | 15.00K |
| 2025-03-20 | Karas Eric | Sell | 10.00K | $14.00 | 140.00K |
| 2025-03-06 | Shawver Laura | Buy | 49.60K | $4.85 | 240.56K |
| 2025-03-06 | Shawver Laura | Sell | 49.60K | $11.21 | 556.05K |
| 2025-03-06 | Shawver Laura | Sell | 49.60K | $4.85 | 240.56K |
| 2025-03-05 | Shawver Laura | Buy | 400 | $4.85 | 1.94K |
| 2025-03-05 | Shawver Laura | Sell | 400 | $11.00 | 4.40K |
| 2025-03-05 | Shawver Laura | Sell | 400 | $4.85 | 1.94K |
| 2025-02-03 | Shawver Laura | Buy | 40.94K | $4.85 | 198.54K |
| 2025-02-03 | Shawver Laura | Buy | 9.06K | $3.15 | 28.55K |
| 2025-02-03 | Shawver Laura | Sell | 50.00K | $12.31 | 615.57K |
| 2025-02-03 | Shawver Laura | Sell | 40.94K | $4.85 | 198.54K |
| 2025-02-03 | Shawver Laura | Sell | 9.06K | $3.15 | 28.55K |
| 2025-01-06 | Shawver Laura | Buy | 50.00K | $3.15 | 157.50K |
| 2025-01-06 | Shawver Laura | Sell | 50.00K | $11.10 | 555.07K |
| 2025-01-06 | Shawver Laura | Sell | 50.00K | $3.15 | 157.50K |
| 2025-01-02 | Fitzpatrick Alexander A | Buy | 152.30K | $10.71 | 1.63M |
| 2025-01-02 | Dorsey Brian | Buy | 261.90K | $10.71 | 2.80M |
| 2025-01-02 | Tanimoto Sarina | Buy | 767.60K | $10.71 | 8.22M |
| 2025-01-02 | Tanimoto Sarina | Buy | 261.90K | $10.71 | 2.80M |
| 2025-01-02 | Lowenthal Richard E | Buy | 767.60K | $10.71 | 8.22M |
| 2025-01-02 | Lowenthal Richard E | Buy | 261.90K | $10.71 | 2.80M |
| 2025-01-02 | Chakma Justin | Buy | 274.10K | $10.71 | 2.94M |
| 2025-01-02 | Scott Kathleen D. | Buy | 176.70K | $10.71 | 1.89M |
| 2025-01-02 | Karas Eric | Buy | 152.30K | $10.71 | 1.63M |
| 2024-12-17 | Tanimoto Sarina | Sell | 50.00K | $11.67 | 583.58K |
| 2024-12-17 | Tanimoto Sarina | Sell | 50.00K | $11.67 | 583.52K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 217, holders +10 vs prior quarter. Ownership 91.81%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 10.86M | 0 | 0.00% | 87.00M |
| RUBRIC CAPITAL MANAGEMENT LP | 8.54M | 540.86K | +6.76% | 68.41M |
| ORBIMED ADVISORS LLC | 8.29M | 0 | 0.00% | 66.39M |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 7.50M | 0 | 0.00% | 60.11M |
| BLACKROCK, INC. | 5.31M | 299.06K | +5.97% | 42.54M |
| TYRO CAPITAL MANAGEMENT LLC | 4.46M | 1.49M | +50.22% | 35.72M |
| ABERDEEN GROUP PLC | 4.17M | 57.01K | +1.39% | 33.41M |
| SR ONE CAPITAL MANAGEMENT, LP | 4.01M | 0 | 0.00% | 32.14M |
| STATE STREET CORP | 3.73M | 85.66K | +2.35% | 29.88M |
| CAPITAL WORLD INVESTORS | 2.75M | 2.75M | New | 22.07M |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.55M | 11.02K | +0.43% | 20.45M |
| MILLENNIUM MANAGEMENT LLC | 2.40M | -3.58M | -59.87% | 19.23M |
| JANNEY MONTGOMERY SCOTT LLC | 2.06M | 48.03K | +2.38% | 16.54M |
| UBS GROUP AG | 1.94M | -320.67K | -14.19% | 15.54M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.70M | 172.19K | +11.28% | 13.61M |
| BOOTHBAY FUND MANAGEMENT, LLC | 1.60M | 1.35M | +539.08% | 12.83M |
| GENERAL AMERICAN INVESTORS CO INC | 1.13M | 405.89K | +55.82% | 9.08M |
| THIRD POINT LLC | 1.00M | 0 | 0.00% | 8.01M |
| PEREGRINE CAPITAL MANAGEMENT LLC | 672.14K | 672.14K | New | 5.38M |
| TEJARA CAPITAL LTD | 607.04K | 396.64K | +188.52% | 4.86M |
| ADAR1 CAPITAL MANAGEMENT, LLC | 601.00K | -760.54K | -55.86% | 4.81M |
| PAVAKI CAPITAL MANAGEMENT LLC | 579.60K | 3.40K | +0.59% | 4.64M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 566.83K | 56.28K | +11.02% | 4.54M |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 551.42K | 551.42K | New | 4.42M |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 551.42K | 18.02K | +3.38% | 4.42M |
Earnings and financials
ARS Pharmaceuticals, Inc. (SPRY) trades at $3.60, with a market cap of $357.51M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn